"Genistein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An isoflavonoid derived from soy products. It inhibits PROTEIN-TYROSINE KINASE and topoisomerase-II (DNA TOPOISOMERASES, TYPE II); activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 PHASE arrest in human and murine cell lines and inhibits PROTEIN-TYROSINE KINASE.
Descriptor ID |
D019833
|
MeSH Number(s) |
D03.383.663.283.266.450.400.375 D03.633.100.150.266.450.400.375
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Genistein".
Below are MeSH descriptors whose meaning is more specific than "Genistein".
This graph shows the total number of publications written about "Genistein" by people in this website by year, and whether "Genistein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 3 | 3 |
2003 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2014 | 4 | 0 | 4 |
2015 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genistein" by people in Profiles.
-
Desai V, Tadinada SM, Shaghaghi H, Summer R, Lai JCK, Bhushan A. Combination Treatment of Biochanin A and Atorvastatin Alters Mitochondrial Bioenergetics, Modulating Cell Metabolism and Inducing Cell Cycle Arrest in Pancreatic Cancer Cells. Anticancer Res. 2024 Jun; 44(6):2307-2323.
-
Desai V, Jain A, Shaghaghi H, Summer R, Lai JCK, Bhushan A. Combination of Biochanin A and Temozolomide Impairs Tumor Growth by Modulating Cell Metabolism in Glioblastoma Multiforme. Anticancer Res. 2019 Jan; 39(1):57-66.
-
Jain A, Lai JC, Bhushan A. Biochanin A inhibits endothelial cell functions and proangiogenic pathways: implications in glioma therapy. Anticancer Drugs. 2015 Mar; 26(3):323-30.
-
Kelly MM, Rearick DC, Overgaard CG, Schoenfuss HL, Arnold WA. Sorption of isoflavones to river sediment and model sorbents and outcomes for larval fish exposed to contaminated sediment. J Hazard Mater. 2015 Jan 23; 282:26-33.
-
Bhardwaj V, Tadinada SM, Jain A, Sehdev V, Daniels CK, Lai JC, Bhushan A. Biochanin A reduces pancreatic cancer survival and progression. Anticancer Drugs. 2014 Mar; 25(3):296-302.
-
Kelly MM, Fleischhacker NT, Rearick DC, Arnold WA, Schoenfuss HL, Novak PJ. Phytoestrogens in the environment, II: microbiological degradation of phytoestrogens and the response of fathead minnows to degradate exposure. Environ Toxicol Chem. 2014 Mar; 33(3):560-6.
-
Rearick DC, Fleischhacker NT, Kelly MM, Arnold WA, Novak PJ, Schoenfuss HL. Phytoestrogens in the environment, I: occurrence and exposure effects on fathead minnows. Environ Toxicol Chem. 2014 Mar; 33(3):553-9.
-
Kelly MM, Arnold WA. Direct and indirect photolysis of the phytoestrogens genistein and daidzein. Environ Sci Technol. 2012 May 15; 46(10):5396-403.
-
Puli S, Jain A, Lai JC, Bhushan A. Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells. Neurochem Res. 2010 Jul; 35(7):986-93.
-
Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. J Gastrointest Surg. 2008 Jan; 12(1):57-66.